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Objective: To observe and characterise vessel injury after
stenting using optical coherence tomography (OCT), to
propose a systematic OCT classification for periprocedural
vessel trauma, to evaluate its frequency in stable versus
unstable patients and to assess its clinical impact during
the hospitalisation period.
Setting: Stenting causes vessel injury.
Design and interventions: All consecutive patients in
whom OCT was performed after stent implantation were
included in the study. Qualitative and quantitative
assessment of tissue prolapse, intra-stent dissection and
edge dissection were performed.
Results: Seventy-three patients (80 vessels) were
analysed. Tissue prolapse within the stented segment
was visible in 78/80 vessels (97.5%). Median number of
tissue prolapse sites was 8 (IQR 4–19), mean (SD) area
1.04 (0.9) mm2. Intra-stent dissection flaps were visible in
69/80 vessels (86.3%) (median number 3 (IQR 1.25–6),
maximum flap length 450 (220) mm). Fifty-five out of 80
vessels (68.8%) showed dissection cavities (median
number 2 (IQR 0–4.75), maximum depth 340 (170) mm).
Edge dissection was visible in 20 vessels (mean (SD)
length flap 744 (439) mm). The frequency of tissue
prolapse or intra-stent dissection was similar in stable and
unstable patients (95.6% vs 100%, p = 0.5 for tissue
prolapse; 91.1% vs 82.9%, p = 0.3 for intra-stent
dissection). There were no events during the hospitali-
sation period.
Conclusions: OCT allows a detailed visualisation of
vessel injury after stent implantation and enables a
systematic classification and quantification in vivo. In this
study, frequency of tissue prolapse or intra-stent
dissections after stenting was high, irrespective of the
clinical presentation of the patients, and was not
associated with clinical events during hospitalisation.
Coronary stent implantation generally creates a
certain degree of injury on the vessel wall.
Pathological studies have demonstrated plaque
compression by the stent and penetration of the
struts into the underlying plaque.1 High-pressure
stenting techniques have proved to be useful for an
optimal stent implantation in order to reduce the
risk of restenosis and subacute thrombosis.
However, this stent deployment strategy may also
increase the risk of vessel damage in the stented
segment or at the edges.2
Optical coherence tomography (OCT) is a high-
resolution imaging technique which allows a
detailed assessment of the anatomical relation
between the stent and the vessel wall.3 4 As a
consequence, various degrees of vessel injury after
stent implantation are frequently detected with
this technique even when they are not visible by
cine-angiography or intravascular ultrasound. The
different types of acute vessel damage caused by
stenting that can be seen by OCT and their
frequency in different clinical scenarios have not
been described yet. Furthermore, the clinical
implications of these OCT findings are not well
established.
The objectives of this study were to observe and
characterise vessel injury after stenting using OCT,
to propose a systematic OCT classification for
periprocedural vessel trauma, to evaluate its
incidence in stable versus unstable (unstable
angina IB/IIB/IIIB Braunwald classification and
ST elevation myocardial infarction (MI)) patients




All consecutive patients in whom OCT was
performed after stent implantation between
January 2007 and December 2008 were included
in the study. All patients gave informed consent.
OCT acquisition
The OCT acquisition was performed using a
commercially available system for intracoronary
imaging (LightLab Imaging, Westford,
Massachusetts, USA). The ImageWire (LightLab
Imaging) consists of an optical fibre core (125 mm)
covered by a protective sheath with a maximum
outer diameter of 0.0190. The acquisition technique
has been previously described.5 6 In seven cases the
occlusive technique was used, in which a proximal,
low-pressure (0.4 atm) occlusion balloon (Helios,
Goodman, Nagoya, Japan) is inflated with simul-
taneous distal flush delivery (lactated ringer; flow
rate 0.8 ml/s) to remove blood from the vessel
lumen. Images were acquired during a pullback
rate of 1.0 mm/s. In 73 cases OCT was acquired
with the non-occlusive technique. In this case, the
ImageWire was positioned distal to the region of
interest using a double lumen catheter (Twin Pass
catheter; Vascular Solutions, Minneapolis, USA)
that had been previously placed in the artery over a
conventional guide wire. The automated pullback
was performed at 3 mm/s while the blood was
removed by the continuous injection of iso-
osmolar contrast (Iodixanol 370; VisipaqueGE
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Health Care, Ireland) at 37u C through the guiding catheter. The
data was stored on CD for offline analysis.
Definitions of acute effects of stent implantation in OCT
Analysis encompassed the intra-stent segment, defined by the
first and the last cross section with a visible strut, and the
adjacent vessel segments 5 mm proximal and distal to the stent
(edge segments).
c Tissue prolapse: convex-shaped, protrusion of tissue between
adjacent stent struts towards the lumen, without disruption
of the continuity of the luminal vessel surface7 (fig 1).
Protrusion of tissue between struts was considered tissue
prolapse only if the distance from the arc connecting
adjacent stent struts to the greatest extent of protrusion
was .50 mm.
c Intra-stent dissection: disruption of the luminal vessel surface
in the stent segment. It can appear in two forms: (a)
dissection: the vessel surface is disrupted and a dissection
flap is visible; (b) cavity: the vessel surface is disrupted and
an empty cavity can be seen (fig 2).
c Edge dissection: disruption of the luminal vessel surface in the
edge segments (within 5 mm proximal and distal to the
stent, no struts are visible) (fig 3).
c Thrombus: irregular mass with dorsal shadowing protruding
in the lumen (mural thrombus) or a luminal mass with
dorsal shadowing that is not connected to the vessel wall
(fig 4).
Quantitative OCT analysis of the acute effects of stent
implantation
The analysed region comprised the intra-stent and edge
segments. The lumen and stent area were measured in 1 mm
intervals along the pullbacks. In the proximal and distal edge
segments, the lumen area was measured. In cases of tissue
prolapse the number of sites with tissue prolapse was counted.
Tissue prolapse length was defined as the distance from the arc
connecting adjacent stent struts to the greatest extent of
protrusion (the maximum and average tissue prolapse length
were calculated). The area of tissue protruding between the
stent struts was also measured (tissue prolapse area) (fig 1).
When there were signs of intra-stent dissection the number of
dissection flaps or cavities was counted and the length of the
flap (from its tip to the joint point with the vessel wall) or the
maximum depth of the cavity (from the lumen to the deepest
cavity point inside the vessel wall) was measured (fig 2). When
edge dissection was present the length of the dissection flap (in
a similar way as described for intra-stent dissection flap) was
Figure 1 Tissue prolapse: defined as convex shaped, protrusion of
tissue between adjacent stent struts towards the lumen without
disruption of the continuity of the luminal vessel surface. The figure
shows a cross section in which tissue prolapse is visible. The amplified
image shows two areas of tissue prolapse. For each tissue prolapse
region the maximum length and the area were measured.
Figure 2 Intra-stent dissection: defined as a disruption of the vessel luminal surface in the stent segment. This entity can appear with two forms: (A)
dissection: the vessel surface is disrupted and a dissection flap is visible. The length of the flap (red arrow) was measured as the distance from its tip to
the joint point with the vessel wall; (B) cavity: the vessel surface is disrupted and an empty cavity can be seen. The maximum depth of the cavity (red
arrow) was measured from the lumen to the deepest cavity point inside the vessel wall.
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measured. The presence of thrombus was qualitatively assessed
and the number of frames with visible thrombus was recorded.
When incomplete stent apposition (defined as separation of at
least one stent strut from the vessel wall not related with a side
branch) was visible, the maximum distance from the endo-
luminal surface of the strut to the vessel wall was measured
(maximum incomplete stent apposition length) To take into
account differences in the stent length, the number of tissue
prolapse sites, number of dissection flaps and number of cavities
were normalised by the stent length and expressed per mm.
The analysts were blinded to the clinical and procedural
characteristics.
Clinical follow-up
The presence of events (death, MI, target lesion revascularisa-
tion, target vessel revascularisation and stent thrombosis)
during the hospitalisation period following stent implantation
was registered. MI included reinfarction (defined as recurrence
of symptoms together with ST elevation or new left bundle
branch block and an increase in cardiac enzymes following
stable or decreasing values) or spontaneous MI (diagnosed by a
rise in creatine kinase-MB fraction of three times the upper limit
of normal together with symptoms and either new ST elevation
or left bundle branch block).
Statistical analysis
Continuous variables are expressed as mean (SD) or median and
interquartile range. Categorical variables are expressed as
percentages. Comparisons between groups were performed
with x2 for categorical variables. Continuous variables were
compared with the Student t test when they had a normal
distribution and with a non-parametric test (Mann–Whitney)
when their distribution was not normal.
RESULTS
Clinical and procedural characteristics
Seventy-three patients, 80 vessels were included in the study.
Table 1 shows the clinical and procedural characteristics.
Acute effects of stent implantation assessed by OCT
The mean (SD) lumen area measured by OCT was 7.16
(1.7) mm2. The minimum lumen area in-stent was 5.65
(1.7) mm2. The mean and minimum stent areas were 7.40
(1.9) and 5.70 (1.76) mm2, respectively.
Fifty-one out of the 80 vessels (63.8%) showed at least one
malapposed strut and the average maximum incomplete stent
apposition length was 281 (145) mm. Findings suggestive of
thrombus were visible in 36/80 vessels (45%). The median
number of frames with visible thrombus was 0 (IQR 0–1) and
the median number of frames with thrombus normalised by the
stent length was 0 (IQR 0–0.06).
Tissue prolapse
Table 2 shows the frequency and quantitative assessment of
tissue prolapse as assessed by OCT.
Intra-stent dissection
Table 2 presents the frequency and quantitative measurements
of intra-stent dissection as assessed by OCT.
Figure 3 Edge dissection: defined as a disruption of the vessel luminal
surface in the edge region (5 mm proximal and distal to the stented
region, no struts are visible).
Figure 4 Thrombus: defined as an irregular mass with dorsal shadowing protruding in the lumen (mural thrombus) (white arrow in A) or a luminal
mass with dorsal shadowing that is not connected to the vessel wall (white arrow in B).
Interventional cardiology
Heart 2009;95:1913–1919. doi:10.1136/hrt.2009.172072 1915
 group.bmj.com on September 30, 2011 - Published by heart.bmj.comDownloaded from 
Edge dissection
In four cases edge regions were not visible. Twenty vessels out
of 76 showed edge dissection. Four vessels showed both
proximal and distal edge dissection. The mean (SD) length of
the dissection flap was 744 (439) mm.
Acute effects of stent implantation as assessed by OCT in
relation to the clinical presentation
The effects of stent implantation in the vessel as assessed by
OCT were compared in stable versus unstable (unstable angina
IB/IIB/IIIB Braunwald classification and ST elevation MI)
patients. Table 3 shows the baseline clinical and procedural
characteristics of the two groups.
The frequency of incomplete stent apposition was not
different between groups (27/45 (60%) for stable vs 24/34
(70.6%) for unstable p = 0.3). The maximum incomplete stent
apposition length was 280 (74) mm for stable and 283 (198) mm
for unstable patients (p = 0.9). Structures suggestive of throm-
bus were visible in 20/45 (44.4%) stable patients vs 16/35
(45.7%) unstable patients (p = 0.9). There were also no
significant differences in the median number of frames with
visible thrombus between stable 0 (IQR 0–1) and unstable 0
(IQR 0–2) patients (p = 0.9). The median number of frames
with visible thrombus normalised by the stent length was 0
(IQR 0–0.05) for stable and 0 (IQR 0–0.08) for unstable
(p = 0.7). Table 4 shows the frequency and quantitative
assessment of tissue prolapse, intra-stent dissections and edge
dissections in patients with stable versus unstable clinical
presentation.
In-hospital events
There were no events (death, MI, target lesion revascularisation,
target vessel revascularisation or stent thrombosis) during the
hospitalisation period.
DISCUSSION
This study proposes a systematic classification and quantifica-
tion of a variety of acute effects of stent implantation on the
vessel wall, as visible by OCT. The main findings are: (a) OCT
allows for a detailed visualisation of periprocedural vessel wall
trauma in coronary stenting and enables a systematic classifica-
tion and quantification in vivo; (b) a very high proportion of
patients, irrespective of their clinical presentation, showed
tissue prolapse or intra-stent dissections visible by OCT after
stent implantation, but this finding was not associated with
clinical events during hospitalisation.
OCT for the detection of vessel injury after stenting
OCT is a light-based technique which can provide in vivo
imaging of the coronary artery with near-histological resolution.
This technique has opened new possibilities for the evaluation
of stents at follow-up, allowing a very detailed assessment of
strut apposition and tissue coverage.8–12 This study demon-
strates its ability to detect and distinguish different types of
Table 1 Baseline clinical and procedural characteristics
Clinical characteristics (n = 73 patients)
Demographics
Age (years), mean (SD) 62 (10)
Male (%) 57 (78.1)
HT (%) 44 (60.3)
DM (%) 14 (19.2)
Dyslipidaemia (%) 46 (63)
Smoker (%) 22 (30.1)
Family history (%) 25 (34.2)
Cardiac history
Previous MI (%) 28 (38.4)
Previous CABG (%) 2 (2.7)
Previous PCI (%) 27 (37)
Clinical presentation
Stable angina (%) 41 (56.2)
Unstable angina (%) 22 (30.1)
STEMI (%) 10 (13.7)
Procedural characteristics (n = 80 vessels)
Vessel
LAD (%) 41 (51.3)
LCX (%) 12 (15)
RCA (%) 27 (33.8)
Stent type
BMS (%) 14 (17.5)
Paclitaxel-eluting stent (%) 5 (6.3)
Sirolimus-eluting stent (%) 4 (5)
Everolimus-eluting stent (%) 44 (55)
Zotarolimus-eluting stent (%) 12 (15)
Tacrolimus-eluting stent (%) 1 (1.3)
Other data
Number of stents, mean (SD) 1.6 (0.8)
Stent diameter, mean (SD) 3.0 (0.4)
Stent length, mean (SD) 33 (17)
Implantation pressure, mean (SD) 16.8 (3)
Predilatation 39 (48.8)
Postdilatation 34 (42.5)
Rotational atherectomy 1 (1.3)
Thrombectomy 5 (6.3)
Results are shown as number (%) unless stated otherwise.
BMS, bare metal stent; CABG, coronary artery bypass graft surgery;
DM, diabetes mellitus; HT, hypertension; LAD, left anterior descending
coronary artery; LCX, left circumflex artery; MI, myocardial infarction;
PCI, percutaneous coronary intervention; RCA, right coronary artery;
STEMI, ST elevation myocardial infarction.
Table 2 Tissue prolapse, intra-stent dissection, edge dissection
frequency and quantitative optical coherence tomography assessment
Tissue prolapse
Tissue prolapse visible, n (%) 78 (97.5)
Number of sites of tissue prolapse, median (IQR) 8 (4–19)
Number of sites of tissue prolapse per mm, median (IQR) 0.3 (0.17–0.69)
Tissue prolapse area (mm2), mean (SD) 1.04 (0.9)
Tissue prolapse area per mm (mm2), mean (SD) 0.03 (0.03)
Tissue prolapse average length (mm), mean (SD) 151 (42)
Tissue prolapse maximum length (mm), mean (SD) 254 (90)
Intra-stent dissection
Intra-stent dissection visible, n (%) 70 (87.5)
Intra-stent dissection flap
Intra-stent dissection flap visible, n (%) 69 (86.3)
Number intra-stent dissection flaps, median (IQR) 3 (1.25–6)
Number intra-stent dissection flaps per mm, median (IQR) 0.10 (0.05–0.22)
Intra-stent dissection flap average length (mm), mean (SD) 300 (130)
Intra-stent dissection flap maximum length (mm), mean (SD) 450 (220)
Intra-stent dissection cavity
Intra-stent dissection cavity visible, n (%) 55 (68.8)
Number cavities, median (IQR) 2 (0–4.75)
Number cavities per mm, median (IQR) 0.07 (0–0.16)
Maximum depth cavity (mm), mean (SD) 340 (170)
Edge dissection
Edge dissection visible, n (%) 20/76 (26.3)
Length edge dissection flap, mean (SD) 744 (439)
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vessel injury during stent implantation. Furthermore, OCT
allows not only qualitative but also quantitative evaluation of
the acute effects of stenting in vivo. Previous reports have
shown that OCT can also visualise vascular effects of other
coronary devices such as balloon-induced dissections and cuts
made by the blades of a cutting balloon.13 Furthermore, OCT
has proved to be useful for the evaluation of strut symmetry or
the presence of intracoronary thrombus after stenting.14–16
Tissue prolapse after stenting
In a postmortem study, compression of the coronary plaque
after stent implantation with protrusion of tissue between the
struts was seen in 94% of the patients.1 This is in agreement
with our study in which tissue prolapse between the struts was
visible in the vast majority of patients. It is in contrast to
intravascular ultrasound (IVUS) studies, which have reported a
relatively low plaque prolapse incidence ranging from 18% to
35%.17 The higher sensitivity of OCT in comparison with IVUS
for the detection of this phenomenon has been previously
published.7 18 The clinical impact of the presence of tissue
prolapse after stenting, however, is not well established. An
IVUS study demonstrated a correlation between creatine
kinase-MB elevation post-procedure and the extent of plaque
prolapse.17 However, IVUS has failed to show differences in the
rate of stent thrombosis or stent restenosis between patients
with and without plaque prolapse.19 20 In our study, even when
almost all patients had visible tissue prolapse by OCT, no
clinical events during hospitalisation occurred. Therefore, non-
flow-limiting tissue prolapse as visualised by OCT in our study
appears to be a benign phenomenon in the short term that
might not require further treatment.
Intra-stent and edge dissections
OCT allows the visualisation of the disruption of the
endoluminal vessel wall continuity in the intra-stent segment
and it can distinguish between the presence of a flap or a region
with loss of material (cavity). IVUS (with an axial resolution of
around 150 mm) is hampered in distinguishing intra-stent
dissections from plaque prolapse. However, by OCT those
two entities can be clearly differentiated and might have
different clinical implications. In our series, despite a high
frequency of visible intra-stent dissections by OCT, no in-
hospital events were registered. However, the long-term impact
of the presence of vessel wall disruption in the stent segment in
the incidence of restenosis or stent thrombosis is not known.
The endothelial integrity is important to prevent thrombus
deposition, and pathological examinations have associated stent
thrombosis with the disruption of the vessel continuity and
prolapse of the necrotic core between stent struts.21 Several
animal and pathological studies have associated vessel injury
with stent restenosis.1 22 On the other hand, non-flow-limiting
edge dissections detected by IVUS have not been associated
with an increase in acute or long-term events such as restenosis
but the impact of intra-stent dissections is not established.23–25
Furthermore, the location of a stent strut floating over an
empty cavity without direct wall contact might also influence
its coverage by tissue at follow-up.26
Acute effects of stent implantation in stable versus unstable
patients
In our series, the frequency of tissue prolapse did not differ
between stable and unstable patients but the tissue prolapse
area was higher in the stable group. This result seems to be in
contradiction with the concept of the underlying plaque type in
stable and unstable patients. In theory, the plaque type in stable
patients might be mainly fibrous while in unstable patients
more lipid-rich and/or thrombosed plaques would be expected
and those might be more prone to prolapse. However, to the
best of our knowledge there are no reported data about
differences in tissue prolapse between stable and unstable
patients. Furthermore, pre-stent OCT examination was not
performed in our sample and therefore no information is
available about the underlying plaque type. No differences in
the frequency of intra-stent or edge dissections were found
between stable and unstable patients.
This study demonstrates the feasibility of a systematic
classification and quantification of periprocedural vessel injury
in vivo. This might allow the development of an injury score,
analogous to the vascular injury score in histopathology, and may
help to study vascular healing and to optimise stent design and
implantation technique in the future. To date the reasons for
stent failure (thrombosis and restenosis) are poorly understood
and vessel trauma after stenting might be a missing link to help us
improve our understanding of this important clinical problem.27 28
However, correlation with clinical events, both early and late,
is required to determine whether these OCT observations have
clinical significance, and this should be the aim of future studies.
Table 3 Clinical and procedural characteristics of stable versus
unstable patients
Characteristics Stable Unstable p Value
Demographics
Age, mean (SD) 62.3 (9.9) 61.7 (10.4) 0.8
Male (%) 34/41 (82.9) 23/32 (71.9) 0.1
HT (%) 25/41 (61) 19/32 (59.4) 0.8
DM (%) 8/41 (19.5) 6/32 (18.8) 0.9
Dyslipidaemia (%) 30/41 (73.2) 16/32 (50) 0.05
Smoker (%) 10/41 (24.4) 12/32 (37.5) 0.3
Family history (%) 16/41 (39) 9/32 (28.1) 0.2
Cardiac history
Previous myocardial infarction (%) 18/41 (43.9) 10/32 (31.3) 0.3
Previous CABG (%) 1/41 (2.4) 1/32 (3.1) 1
Previous PCI (%) 16/41 (39) 11/32 (34.4) 0.8
Vessel
LAD (%) 22/45 (48.9) 19/35 (54.3)
LCX (%) 8/45 (17.8) 4/35 (11.4) 0.8
RCA (%) 15/45 (33.3) 12/35 (34.3)
Stent type
BMS (%) 11/45 (24.4) 3/35 (8.6) 0.08
Paclitaxel-eluting stent (%) 5/45 (11.1) 0
Sirolimus-eluting stent (%) 1/45 (2.2) 3/35 (8.6)
Everolimus-eluting stent (%) 19/45 (42.2) 25/35 (71.4)
Zotarolimus-eluting stent (%) 8/45 (17.8) 4/35 (11.4)
Tacrolimus-eluting stent (%) 1/45 (2.2) 0
Other data
Number of stents, mean (SD) 1.5 (0.8) 1.8 (0.8) 0.2
Stent diameter (mm), mean (SD) 3.0 (0.5) 3 (0.3) 0.7
Stent length (mm), mean (SD) 33 (17) 35 (17) 0.5
Implantation pressure (atm), mean
(SD)
17 (4) 17 (3) 0.7
Predilatation (%) 25/45 (55.6) 14/35 (40) 0.2
Postdilatation (%) 21/45 (46.7) 13/35 (37.1) 0.4
Rotational atherectomy (%) 1/45 (2.2) 0 1
Results are shown as number (%) unless stated otherwise.
BMS, bare metal stent; CABG, coronary artery bypass graft surgery; DM, diabetes
mellitus; HT, hypertension; LAD, left anterior descending coronary artery; LCX, left
circumflex artery; PCI, percutaneous coronary intervention; RCA, right coronary artery.
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Limitations
The lack of clinical events during the study period does not
allow a proper correlation of OCT-assessed vessel trauma with
clinical outcome and it is the main limitation of the study.
Intra-stent dissection and tissue prolapse were almost universal.
Therefore identification of their presence alone has no
significance. In order to find a more discriminatory OCT
measure of vessel trauma we described different quantitative
parameters for each type of post-stenting vessel injury.
However, the lack of clinical events did not allow us to
evaluate which parameter may be clinically significant. We
assessed the acute effects of stent implantation visible by
OCT and their clinical impact at short-term follow-up. Long-
term follow-up studies including OCT imaging are needed in
order to better define the clinical implications of these
findings. The clinical presentation classification used has
limitations as it included syndromes with different physio-
pathology (unstable angina/NSSTMI and STEMI) in the same
group. However, owing to the limited sample size, it was not
possible to divide the population into multiple subgroups. We
acknowledge that the stent type might influence the vessel
trauma observed by OCT. However, owing to the hetero-
geneity of the population, with different drug-eluting stents
and a limited number of bare metal stents, no comparison
between stent types was performed.
CONCLUSIONS
OCT allows for a detailed visualisation of periprocedural vessel
wall trauma in coronary stenting and enables a systematic
classification and quantification in vivo. In our study, the
incidence of tissue prolapse or intra-stent dissections after stent
implantation was high, irrespective of the clinical presentation
of the patients, and was not associated with clinical events
during the hospitalisation period.
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